Copay accumulator adjustment programs significantly increase patient financial burden
By Xcenda
This issue brief highlights the potential drawbacks of copay accumulator adjustment programs on patient cost-sharing for prescription medications. These programs limit the amount of copay assistance that can be applied towards patients' deductibles and out-of-pocket maximums, resulting in higher out-of-pocket costs for patients. This could lead to challenges in medication adherence and potentially impact health outcomes. The brief examines the implications of these programs on affordability and adherence in select therapeutic areas and suggests policy solutions to ensure that patients can continue to access the medications they need. Download to learn more.